FDA Warning Letter — Harper Meds

Case 728281 — FEI 3044020867

The FDA took a Warning Letter action against Harper Meds on June 8, 2026 (Jersey City, NJ). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Harper Meds
Date
June 8, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Jersey City, NJ (United States)